Señales en vivo de MYNZ | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (9 may 2024 @ 16:00):

Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics...

Stats
Volumen de hoy	171 482
Volumen promedio	105 662
Capitalización de mercado	14.42M
EPS	$0 ( 2024-04-08 )
Próxima fecha de ganancias	( $-0.310 ) 2024-05-21
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.410
ATR14	$0.00600 (0.92%)

Volumen Correlación

Largo: -0.14 (neutral)

Corto: -0.61 (weak negative)

Signal:(46.694) Neutral

Mainz Biomed B.V. Correlación

10 Correlaciones Más Positivas
BNDW	0.809
GLPI	0.807
SOHO	0.805
EWZS	0.801
TLT	0.801

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Mainz Biomed B.V. Correlación - Moneda/Commodity

0.32
( neutral )

-0.27
( neutral )

0.00
( neutral )

-0.63
( weak negative )

0.56
( weak )

Mainz Biomed B.V. Finanzas

Annual	2023
Ingresos:	$895 479
Beneficio Bruto:	$509 659 (56.91 %)
EPS:	$-1.620

FY	2023
Ingresos:	$895 479
Beneficio Bruto:	$509 659 (56.91 %)
EPS:	$-1.620

FY	2022
Ingresos:	$529 877
Beneficio Bruto:	$182 151 (34.38 %)
EPS:	$-1.870

FY	2021
Ingresos:	$577 348
Beneficio Bruto:	$177 622 (30.77 %)
EPS:	$-1.620

Financial Reports:

No articles found.

Mainz Biomed B.V.

Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.